Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

401 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study.
Ferrara G, Losi M, D'Amico R, Roversi P, Piro R, Meacci M, Meccugni B, Dori IM, Andreani A, Bergamini BM, Mussini C, Rumpianesi F, Fabbri LM, Richeldi L. Ferrara G, et al. Among authors: richeldi l. Lancet. 2006 Apr 22;367(9519):1328-34. doi: 10.1016/S0140-6736(06)68579-6. Lancet. 2006. PMID: 16631911 Clinical Trial.
Performance of tests for latent tuberculosis in different groups of immunocompromised patients.
Richeldi L, Losi M, D'Amico R, Luppi M, Ferrari A, Mussini C, Codeluppi M, Cocchi S, Prati F, Paci V, Meacci M, Meccugni B, Rumpianesi F, Roversi P, Cerri S, Luppi F, Ferrara G, Latorre I, Gerunda GE, Torelli G, Esposito R, Fabbri LM. Richeldi L, et al. Chest. 2009 Jul;136(1):198-204. doi: 10.1378/chest.08-2575. Epub 2009 Mar 24. Chest. 2009. PMID: 19318676 Free article. Clinical Trial.
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments.
De Biasi S, Cerri S, Bianchini E, Gibellini L, Persiani E, Montanari G, Luppi F, Carbonelli CM, Zucchi L, Bocchino M, Zamparelli AS, Vancheri C, Sgalla G, Richeldi L, Cossarizza A. De Biasi S, et al. Among authors: richeldi l. BMC Med. 2015 Nov 9;13:277. doi: 10.1186/s12916-015-0515-0. BMC Med. 2015. PMID: 26552487 Free PMC article.
Multidrug-resistant tuberculosis outbreak in an Italian prison: tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays.
Bedini A, Garlassi E, Stentarelli C, Petrella S, Meacci M, Meccugni B, Meschiari M, Franceschini E, Cerri S, Brasacchio A, Rumpianesi F, Richeldi L, Mussini C. Bedini A, et al. Among authors: richeldi l. New Microbes New Infect. 2016 Apr 7;12:45-51. doi: 10.1016/j.nmni.2016.03.010. eCollection 2016 Jul. New Microbes New Infect. 2016. PMID: 27222718 Free PMC article.
Management of multidrug-resistant tuberculosis in Italy.
Ferrara G, Richeldi L, Bugiani M, Cirillo D, Besozzi G, Nutini S, Casali L, Fiorentini F, Codecasa LR, Migliori GB. Ferrara G, et al. Among authors: richeldi l. Int J Tuberc Lung Dis. 2005 May;9(5):507-13. Int J Tuberc Lung Dis. 2005. PMID: 15875921
Genetic testing in diffuse parenchymal lung disease.
Spagnolo P, Luppi F, Cerri S, Richeldi L. Spagnolo P, et al. Among authors: richeldi l. Orphanet J Rare Dis. 2012 Oct 17;7:79. doi: 10.1186/1750-1172-7-79. Orphanet J Rare Dis. 2012. PMID: 23075428 Free PMC article. Review.
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
Richeldi L, Costabel U, Selman M, Kim DS, Hansell DM, Nicholson AG, Brown KK, Flaherty KR, Noble PW, Raghu G, Brun M, Gupta A, Juhel N, Klüglich M, du Bois RM. Richeldi L, et al. N Engl J Med. 2011 Sep 22;365(12):1079-87. doi: 10.1056/NEJMoa1103690. N Engl J Med. 2011. PMID: 21992121 Free article. Clinical Trial.
401 results